Literature DB >> 6254586

Involvement of a central alpha-adrenoceptor system in antidepressant potentiation of hyperthermia induced by thyrotropin releasing hormone.

M Desiles, A J Puech, R Rips.   

Abstract

Thyrotropin releasing hormone (TRH) causes hyperthermia in mice which is potentiated by tricyclic antidepressants (nortriptyline, imipramine, clomipramine, amitriptyline), the monoamine oxidase inhibitor, tranylcypromine, and various other antidepressants (maprotiline, nomifensin, viloxazine). Only iprindole is ineffective. The effect of mianserin, itself hypothermic, could not be interpreted. A property shared by the potentiating substances seems to be activation of a central adrenoceptor system. The potentiation of TRH-induced hyperthermia which seems to be specific to antidepressants might be used in the selection of antidepressants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254586      PMCID: PMC2044250          DOI: 10.1111/j.1476-5381.1980.tb07885.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain.

Authors:  J Vetulani; R J Stawarz; J V Dingell; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

2.  Effect of iprindole on norepinephrine turnover and transport.

Authors:  B N Rosloff; J M Davis
Journal:  Psychopharmacologia       Date:  1974

3.  Blockade of noradrenaline uptake by 34276-Ba, a new antidepressant drug.

Authors:  L Maître; M Staehelin; H J Bein
Journal:  Biochem Pharmacol       Date:  1971-09       Impact factor: 5.858

4.  Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.

Authors:  H H Keller; G Bartholini; A Pletscher
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

5.  Evaluation of thyrotropin-releasing hormone as a potential antidepressant agent in the conscious dog.

Authors:  B Hine; I Sanghvi; S Gershon
Journal:  Life Sci       Date:  1973-12-16       Impact factor: 5.037

6.  TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

7.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.

Authors:  P Hunt; M Kannengiesser; J Raynaud
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

8.  Thyrotropin-releasing hormone (TRH)-induced hyperthermia and behavioral excitation in rabbits.

Authors:  A Horita; M A Carino
Journal:  Psychopharmacol Commun       Date:  1975

9.  Thyrotropin releasing hormone (TRH): DOPA potentiation and biogenic amine studies.

Authors:  N P Plotnikoff; G R Breese; A J Prange
Journal:  Pharmacol Biochem Behav       Date:  1975 Jul-Aug       Impact factor: 3.533

10.  Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).

Authors:  C Braestrup; J Scheel-Krüger
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

View more
  3 in total

1.  Use of potentiation of thyrotrophin releasing hormone (TRH)-induced hyperthermia as a test for screening antidepressants which activate alpha-adrenoceptor systems.

Authors:  M Desiles; R Rips
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

2.  The effect of highly selective inhibitors of the uptake of noradrenaline or 5-hydroxytryptamine on TRH-induced hyperthermia in mice.

Authors:  L Pawłowski; H Kwiatek
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Potentiation by TRH of the effect of imipramine on the forced-swimming test.

Authors:  V Reny-Palasse; R Rips
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.